Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Merck
Citi
UBS
Queensland Health
Accenture
Boehringer Ingelheim
US Department of Justice

Generated: November 19, 2018

DrugPatentWatch Database Preview

Drugs with Dosage: INJECTABLE;SPINAL

« Back to Dashboard

Drugs with Dosage: INJECTABLE;SPINAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Fresenius Kabi Usa XYLOCAINE 1.5% W/ DEXTROSE 7.5% lidocaine hydrochloride INJECTABLE;SPINAL 016297-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Hospira LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% lidocaine hydrochloride INJECTABLE;SPINAL 083914-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride INJECTABLE;SPINAL 071202-001 Apr 15, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;SPINAL 071810-001 Dec 11, 1987 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Baxter Hlthcare Corp BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;SPINAL 207266-001 Jul 25, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Astrazeneca XYLOCAINE 5% W/ GLUCOSE 7.5% lidocaine hydrochloride INJECTABLE;SPINAL 010496-002 Jul 7, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Hospira MARCAINE bupivacaine hydrochloride INJECTABLE;SPINAL 018692-001 May 4, 1984 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial INJECTABLE;SPINAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Covington
Daiichi Sankyo
Cantor Fitzgerald
Dow
Merck
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.